Global trends and frontiers of research on meibomian gland dysfunction since the millennium: A bibliometric analysis

Abstract

Abstract Objective To report publication trends since 2000 and identify significant journals, nations, authors associated with meibomian gland dysfunction (MGD) research.Results 1,448 papers published between 1 January 2000 to 1 January 2023 were included. MGD has developed into an incredibly interesting topic (with relative research interest ranging from 0.0005% in 2000 to 0.0082% in 2022). The USA, China, and Japan were the top nations with the most publications, producing the journals, writers, and organizations that published the majority of the literature. The country with the fastest-growing number of publications was China (from 0 in 2000 to 66 in 2022). The journal with the most papers on MGD is Cornea. The most papers were contributed by Arita, Reiko, and Keio University, among writers and organizations, respectively. Dry eye disease and ocular surface were the main topics of earlier study, whereas intense pulsed light (IPL) was the latest hotspot and has been used for the therapy of MGD.Conclusion Our findings may aid in understanding MGD's present and potential future developments. According to the quantity of publications, journals, authors, and institutions, China, the USA, and Japan have the most influence. The IPL, pathophysiology and morphology are highlighted in current research on MGD.